Foundry Partners’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
BCM
Foundry Partners's RGEN Position: Q2 2024 in Review
Foundry Partners sold out of Repligen (RGEN) in Q2 2024, closing a stake of 1,135 shares — an estimated $209K sold.
Foundry Partners first reported a position in RGEN in Q4 2016 and held it in 18 quarters. The position peaked at $3.24M in Q2 2017. 455 funds tracked by Wall St. Rank hold RGEN as of Q2 2024.
- Foundry Partners reported no remaining Repligen position as of Q2 2024 after selling out during the quarter.
- Foundry Partners sold 1,135 Repligen shares in Q2 2024, an estimated $209K.
- Foundry Partners first reported a position in Repligen in Q4 2016 and held it in 18 quarters.
- Foundry Partners's Repligen position peaked at $3.24M in Q2 2017.
- 455 funds tracked by Wall St. Rank held Repligen as of Q2 2024.
Based on Foundry Partners's 13F filing for Q2 2024, filed 5 Aug 2024.